Raadr Inc (RDAR)

[Bubae]

The share buy back narrative was as important to getting those reg A shares sold as not revealing the dilution in the weekly share count updates for months. This tactic should be adopted by all OTC tickers to sell their reg A offerings because lying to shareholders is very effective. There is no amount of due diligence that can prevent traders from being scammed if the company is willing to lie and manipulate to this degree. These Mexedia managers have taken it to a whole new level.

Bubae
Monday, August 25, 2025 7:56:48 AM
Post# 48935 of 48983
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176615239

The company can not hide from what they did. The con to sell 1.3 billion shares of that reg A offering before they filed the Q2 report had two very important parts. The first is that they updated nearly weekly the share structure on the OTC site for months without revealing the ongoing dilution. Post # 48002 shows the near weekly updates since the beginning of the year showing the 25 million shares of the first tranche of the reg A being issued. After that they report zero increases.

The second very important part is the false share buy back narrative. This gave the company a certain air of legitimacy to be able to buy back shares though the business is cash flow negative. This also encourages people to buy the stock, but convincing people hold was key to the price increase. The company then tweets out on the 27th "buyback has started today!". The sales of the reg A began in earnest on that day. Details and links in post# 48921 linked below.